Cellebrite DI Ltd.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Revenue from Contract with Customer, Excluding Assessed Tax $171.9m $194.9m $246.2m $270.7m $325.1m $401.2m $475.7m
Cost of Revenue $35.8m $37.9m $42.6m $50.7m $53.2m $62.6m $75.2m
Gross Profit, Total $136.0m $157.0m $203.7m $219.9m $271.9m $338.6m $400.5m
Operating Expenses, Total $137.6m $147.8m $189.9m $218.9m $238.6m $281.7m $334.0m
Operating Income (Loss), Total ($1.5m) $9.2m $13.8m $1.0m $33.2m $56.9m $66.5m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total $1.4m $11.4m $82.3m $120.8m ($75.6m) ($276.0m) $90.7m
Net Income (Loss) ($1.9m) $5.8m $71.4m $120.8m ($81.1m) ($283.0m) $78.3m
Basic net income (loss) per share attributable to ordinary shareholders $0 ($1) $1 $1 $1 $1 $1
Basic net income (loss) per ordinary share (in USD per share) ($0) ($0) $0 $1 ($0) ($1) $0
Diluted net income (loss) per share (in USD per share) ($0) ($0) $0 $1 ($0) ($1) $0
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares) ($0) $0 $0 $1 ($0) ($1) $0
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares) ($0) $0 $0 $1 ($0) ($1) $0
Research and Development Expense $46.6m $54.4m $65.5m $80.6m $84.4m $98.4m $113.9m
Selling and Marketing Expense $61.6m $61.3m $76.4m $97.4m $110.8m $132.4m $154.8m
General and Administrative Expense $29.4m $32.1m $47.9m $40.9m $43.4m $50.9m $65.3m
Nonoperating Income (Expense) $2.9m $2.2m $68.5m $119.7m ($108.8m) ($332.9m) $24.2m
Income Tax Expense (Benefit) $3.3m $5.6m $10.9m ($45k) $5.5m $7.0m $12.4m